Video: Flying High With Martine Rothblatt and Kyle Clark 

Vermont startup Beta Technologies has raised hundreds of millions of dollars to fund its drive to pioneer electric aviation.

On Saturday, October 23, 2021, Seven Days staff writer Chelsea Edgar interviewed Beta founder and CEO Kyle Clark and its first customer, Martine Rothblatt, CEO of United Therapeutics, during a special keynote presentation at the end of the Vermont Tech Jam at Hula in Burlington.

Based at Burlington International Airport, Beta Technologies is trying to do something that’s never been done before: manufacture a fleet of battery-powered aircraft capable of transporting people and cargo, and design the battery-charging infrastructure to support it.

Hundreds of companies around the world are racing to build electric planes; air travel is a significant source of the greenhouse gas emissions driving climate change. Beta is one of the leaders of the pack. It has already received orders for planes from customers including United Parcel Service, aka UPS.

Vermont native Kyle Clark founded Beta in 2017. He’s a pilot, engineer and former hockey pro who had a vision for an electric aircraft that could take off and land like a helicopter, then fly like a fixed-wing plane. One of the company’s other competitive advantages? Martine Rothblatt, Beta’s first customer, who now serves as one of the company’s directors.

Rothblatt has been blazing trails for decades. A regulatory attorney, she cofounded Sirius Satellite Radio and helped develop the technology that made it possible. In 2013, she was the highest-paid female CEO in the U.S., earning $38 million. She’s also a pioneer in the field of digitizing human consciousness. The ambassador for her efforts in that realm, Vermont-based Terasem Movement Foundation, is a robot, Bina48, created using the downloaded memories of her wife, Bina.

In the 1990s, the couple’s youngest daughter was diagnosed with pulmonary arterial hypertension, a fatal disease. In an effort to save her daughter’s life, Rothblatt researched possible treatments and started a biotech firm, United Therapeutics, to pursue them. Today the company sells five FDA-approved medicines that treat the disease; her daughter now works for the company. Still, the only cure for the disease is a lung transplant, and there’s a severe shortage of available organs. So United Therapeutics plans to manufacture them. To deliver the organs to recipients in time, the company needs a special kind of aircraft. That’s where Beta comes in.